Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles.

NPJ Vaccines · 2025 · PMC12618464 · PMID 41238582

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, Group 5 sera showed a trend of increased HIV-1 Env trimer-binding (Fig. 5G ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.